Equity Brief · Consumer Cyclical2026-05-20
DHI·Consumer Cyclical

DR Horton Inc

I · AI Analysis

The brief

D.R. Horton builds and sells residential homes — primarily single-family detached houses, but also townhomes and duplexes — in markets spread across the eastern, northern, southeastern, south central, southwestern, and northwestern United States [Yahoo Finance]. Beyond homebuilding, the company offers mortgage financing and title services to buyers, develops residential lots for sale, and operates rental properties and insurance-related businesses [Yahoo Finance].

D.R. Horton is the largest homebuilder in the United States, constructing and selling single-family homes across 36 states in 126 markets [Yahoo Finance]. The company reported $34.3B in revenue with a market cap of $38.2B, though revenue declined 6.9% year-over-year [Yahoo Finance]. With strong free cash flow of $3.3B and a healthy balance sheet (Altman Z-score of 5.9), the company remains financially solid despite recent headwinds in the housing market [Yahoo Finance] [Sentinellis calculation].

D.R. Horton is financially healthy with strong cash generation and low debt, despite a revenue pullback in the past year [Yahoo Finance].

The brief AI analysisConfidence 8/10

Sentinellis health

7.9/10

Financially healthy

Market capitalisation

$38.2B

Revenue (TTM)

$34.3B

Explainers

How we read these numbers

Plain-English guides · no account needed

II · Recent news

What moved

1 story · ranked by relevance

  • Macro2026-05-19

    D.R. Horton, Inc. to Release 2026 Third Quarter Earnings on July 21, 2026

    Yahoo Finance

Premium · Free with any account

Revenue declined 6.9% year-over-year, reflecting softer housing market conditions or demand headwinds that could persist if mortgage rates remain elevated or consumer affordability worsens [Yahoo Finance].

1 of 4 risks in this report

Risks

4

Opportunities

4

Red flags

2

Leadership

10

9 more findings in the full report — free with any account.

Unlock the full DR Horton Inc analysis

Create a free account to access the complete AI-generated report with inline citations.

  • 4 risks, 4 opportunities and 2 red flags — each with its source
  • 100+ financial metrics with charts and benchmarks
  • Full news summaries with source links
  • Executive team and compensation details
  • PDF export for offline use
Unlock all 10 findings3 free reports · No credit card

III · Related

You might also read

Same sector · Consumer Cyclical — or comparable health

Want this for your watchlist?

Read three companies free. No card.

Get 3 free reports

Produced 20 May 2026, 19:54 UTC

Figures come from company filings and market data. The Sentinellis health score and the wording attached to it are our interpretation of those figures, not numbers the company reported.

Not investment advice and not a recommendation to buy or sell. Sentinellis holds no positions in the companies it covers, takes no payment from issuers, and has no broker referral arrangements.

How every figure and score is calculated